Alkem Laboratories has incorporated wholly owned subsidiary (WOS) of the company in the name of ‘Alixer Nexgen Therapeutics’. The company has incorporated WOS on July 12, 2024. Alixer Nexgen Therapeutics has been incorporated to conduct research, studies, innovation work and develop novel medicines and treatments in key therapeutic areas and to establish global collaborations.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.